Vical Inc. said Friday that it has filed a registration statementwith the Securities and Exchange Commission for a publicoffering of 2 million shares of common stock.
Hambrecht & Quist Inc. and Vector Securities International Inc.are co-managing the offering and have an option for 300,000additional shares to cover overallotments.
Vical's stock (NASDAQ:VICL) closed unchanged at $9.25 a shareon Friday.
Vical, a gene therapy company based in San Diego, raised $10million in an initial public offering of 2 million shares at $5 pershare in March -- far less than the company had hoped. WhenVical filed its registration statement for the IPO in January, theoffering was for 3 million shares at $9-11 per share.
(c) 1997 American Health Consultants. All rights reserved.